1 day BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst …
Nasdaq 100 · Pharmaceuticals · Science
X